Alerts will be sent to your verified email
Verify Email
SYSCHEM
|
Syschem (India)
|
Bafna Pharma
|
Ambalal Sarabhai Ent
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-15.43 % | -52.11 % | 19.11 % |
|
5yr Avg Net Profit Margin
|
-1.1 % | -36.55 % | 10.89 % |
|
Price to Book
|
2.68 | 4.85 | 1.71 |
|
P/E
|
122.95 | 29.95 | 18.65 |
|
5yr Avg Cash Conversion Cycle
|
2.82 Days | 0.18 Days | -37.53 Days |
|
5yr Average Interest Coverage Ratio
|
8.6 | -5.68 | 9.88 |
|
5yr Avg ROCE
|
-1.51 % | -11.61 % | 24.01 % |
|
5yr Avg Operating Profit Margin
|
1.15 % | -21.98 % | 5.29 % |
|
5 yr average Debt to Equity
|
0.49 | 1.41 | 0.32 |
|
5yr CAGR Net Profit
|
n/a | 12.0 % | -30.01 % |
|
5yr Average Return on Assets
|
-0.74 % | -16.11 % | 8.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.71 % | 75.0 % | 31.35 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
34.93 % | -15.12 % | 0.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Syschem (India)
|
Bafna Pharma
|
Ambalal Sarabhai Ent
|
|---|